Pingyu Wang

2.3k total citations
82 papers, 1.7k citations indexed

About

Pingyu Wang is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Pingyu Wang has authored 82 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 38 papers in Cancer Research and 10 papers in Biomedical Engineering. Recurrent topics in Pingyu Wang's work include MicroRNA in disease regulation (30 papers), Cancer-related molecular mechanisms research (21 papers) and Circular RNAs in diseases (15 papers). Pingyu Wang is often cited by papers focused on MicroRNA in disease regulation (30 papers), Cancer-related molecular mechanisms research (21 papers) and Circular RNAs in diseases (15 papers). Pingyu Wang collaborates with scholars based in China, United States and Spain. Pingyu Wang's co-authors include Shuyang Xie, Youjie Li, Can Zhang, Gao Zong-hua, Zhen Yue, Ning Xie, Ranran Wang, Shuai Zhang, Yunfei Yan and Yanxia Zhang and has published in prestigious journals such as PLoS ONE, PLANT PHYSIOLOGY and Scientific Reports.

In The Last Decade

Pingyu Wang

76 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pingyu Wang China 24 940 706 148 138 126 82 1.7k
Mengying Wu China 25 1.6k 1.7× 617 0.9× 113 0.8× 85 0.6× 108 0.9× 93 2.4k
Jing Guo China 29 1.3k 1.4× 769 1.1× 201 1.4× 112 0.8× 41 0.3× 87 2.2k
Lijie Jiang China 23 942 1.0× 442 0.6× 61 0.4× 126 0.9× 94 0.7× 100 2.1k
Shuyang Xie China 28 1.2k 1.3× 850 1.2× 185 1.3× 40 0.3× 209 1.7× 123 2.3k
F. Russell Westwood United Kingdom 16 700 0.7× 556 0.8× 107 0.7× 156 1.1× 71 0.6× 29 1.8k
Siqi Wang China 27 1.0k 1.1× 431 0.6× 43 0.3× 126 0.9× 197 1.6× 104 1.7k
Maria Bastaki United States 21 623 0.7× 260 0.4× 118 0.8× 171 1.2× 57 0.5× 39 1.4k
Aysa Rezabakhsh Iran 24 793 0.8× 278 0.4× 63 0.4× 75 0.5× 186 1.5× 83 1.6k
Qingling Yang China 29 1.2k 1.3× 583 0.8× 563 3.8× 118 0.9× 82 0.7× 114 2.4k
Rodrigo Arreola Mexico 12 641 0.7× 267 0.4× 54 0.4× 217 1.6× 84 0.7× 28 1.8k

Countries citing papers authored by Pingyu Wang

Since Specialization
Citations

This map shows the geographic impact of Pingyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingyu Wang more than expected).

Fields of papers citing papers by Pingyu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingyu Wang. The network helps show where Pingyu Wang may publish in the future.

Co-authorship network of co-authors of Pingyu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Pingyu Wang. A scholar is included among the top collaborators of Pingyu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingyu Wang. Pingyu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Meiling, Ning Xie, Chunxia Wu, et al.. (2025). Novel nanoparticle-combined therapy through EGFR and PD-L1 blockade: PFPR-siRNA-mediated suppressing NSCLC proliferation via PDT and enhanced antitumor immunity. Colloids and Surfaces B Biointerfaces. 259. 115284–115284.
2.
Zhang, Yuqiang, Danyang Wang, Yiying Wei, et al.. (2025). Celastrol loaded nanocomplex for painless tumor therapy via YAP inhibition. Scientific Reports. 15(1). 13133–13133.
3.
Li, Dayong, et al.. (2025). Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(11). 3327–3346.
4.
Zhang, Xia, Shudi Liu, Youjie Li, et al.. (2025). Evaluating the “double-edged sword” effects of sulfur dioxide on lung tissue inflammation via fluorescent probe. Microchemical Journal. 215. 114303–114303. 1 indexed citations
5.
Wang, Pingyu, et al.. (2024). The phytocytokine systemin enhances postharvest tomato fruit resistance to Botrytis cinerea. Postharvest Biology and Technology. 210. 112738–112738. 8 indexed citations
6.
Wang, Ranran, Pingyu Wang, Jiaxiang Zhang, et al.. (2024). IL-12-Overexpressed Nanoparticles Suppress the Proliferation of Melanoma Through Inducing ICD and Activating DC, CD8+ T, and CD4+ T Cells. International Journal of Nanomedicine. Volume 19. 2755–2772. 16 indexed citations
7.
Zhou, Tong, et al.. (2024). The application of nanoparticles in delivering small RNAs for cancer therapy. Discover Oncology. 15(1). 500–500. 3 indexed citations
8.
Qu, Guiwu, Youjie Li, Pingyu Wang, et al.. (2024). Danshensu methyl ester attenuated LPS-induced acute lung injury by inhibiting TLR4/NF-κB pathway. Respiratory Physiology & Neurobiology. 322. 104219–104219. 2 indexed citations
9.
Liang, Yan, Pingyu Wang, Hongfang Sun, et al.. (2023). Dual Stimuli-Responsive Micelles for Imaging-Guided Mitochondrion-Targeted Photothermal/Photodynamic/Chemo Combination Therapy-Induced Immunogenic Cell Death. International Journal of Nanomedicine. Volume 18. 4381–4402. 6 indexed citations
10.
Hou, Chih‐Yao, Sulfath Hakkim Hazeena, Shu‐Ling Hsieh, et al.. (2022). Effect of D-Limonene Nanoemulsion Edible Film on Banana (Musa sapientum Linn.) Post-Harvest Preservation. Molecules. 27(19). 6157–6157. 25 indexed citations
11.
Zhang, Meiling, Youjie Li, Hongfang Sun, et al.. (2022). WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis. Frontiers in Oncology. 12. 1032850–1032850. 7 indexed citations
12.
Hu, Jinxia, Yanmei Li, Ranran Wang, et al.. (2021). RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma. Frontiers in Oncology. 11. 733175–733175. 4 indexed citations
13.
Yu, Hui, Deqiang Wang, Youjie Li, et al.. (2021). MnO2 nanoflowers as a multifunctional nano-platform for enhanced photothermal/photodynamic therapy and MR imaging. Biomaterials Science. 9(10). 3662–3674. 45 indexed citations
14.
Li, Jinghua, Shanshan Sun, Anqi Zhang, et al.. (2018). Diagnostic and prognostic value of microRNA-628 for cancers. Journal of Cancer. 9(9). 1623–1634. 8 indexed citations
15.
Zhang, Yanxia, Yunfei Yan, Youjie Li, et al.. (2016). Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth. Cell Death and Disease. 7(12). e2528–e2528. 30 indexed citations
16.
Li, Xinxin, Pingyu Wang, Xue Zhou, et al.. (2015). Reduced expression levels of let-7c in human breast cancer patients. Oncology Letters. 9(3). 1207–1212. 33 indexed citations
17.
Wang, Pingyu, Gao Zong-hua, Zhonghua Jiang, et al.. (2013). The Associations of Single Nucleotide Polymorphisms in miR-146a, miR-196a and miR-499 with Breast Cancer Susceptibility. PLoS ONE. 8(9). e70656–e70656. 33 indexed citations
18.
Wang, Pingyu, et al.. (2013). Higher expression of circulating miR-182 as a novel biomarker for breast cancer. Oncology Letters. 6(6). 1681–1686. 65 indexed citations
19.
Wang, Pingyu, et al.. (2011). miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects. Experimental and Therapeutic Medicine. 3(2). 324–330. 15 indexed citations
20.
Wang, Pingyu, et al.. (2010). Application of problem-based learning teaching mode in medical statistics to cultivating innovative talents.. Xiandai shengwu yixue jinzhan. 10(18). 3557–3559.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengying Wu Breakdown of academic impact, for papers by Jing Guo Breakdown of academic impact, for papers by Lijie Jiang Breakdown of academic impact, for papers by Shuyang Xie Breakdown of academic impact, for papers by F. Russell Westwood Breakdown of academic impact, for papers by Siqi Wang Breakdown of academic impact, for papers by Maria Bastaki Breakdown of academic impact, for papers by Aysa Rezabakhsh Breakdown of academic impact, for papers by Qingling Yang Breakdown of academic impact, for papers by Rodrigo Arreola
Rankless by CCL
2026